Naffouje SA - Search Results

1

Nontoxic Tumor-Targeting Optical Agents for Intraoperative Breast Tumor Imaging.

Naffouje SA, Goto M, Coward LU, Gorman GS, Christov K, Wang J, Green A, Shilkaitis A, Das Gupta TK, Yamada T. Naffouje SA, et al. J Med Chem. 2022 May 26;65(10):7371-7379. doi: 10.1021/acs.jmedchem.2c00417. Epub 2022 May 11. J Med Chem. 2022. PMID: 35544687

2

A Method of Tumor In Vivo Imaging with a New Peptide-Based Fluorescent Probe.

Naffouje S, Goto M, Ryoo I, Green A, Das Gupta TK, Yamada T. Naffouje S, et al. Methods Mol Biol. 2022;2394:857-865. doi: 10.1007/978-1-0716-1811-0_45. Methods Mol Biol. 2022. PMID: 35094362 Free PMC article.

3

Image-guided surgery with a new tumour-targeting probe improves the identification of positive margins.

Goto M, Ryoo I, Naffouje S, Mander S, Christov K, Wang J, Green A, Shilkaitis A, Das Gupta TK, Yamada T. Goto M, et al. EBioMedicine. 2022 Feb;76:103850. doi: 10.1016/j.ebiom.2022.103850. Epub 2022 Jan 30. EBioMedicine. 2022. PMID: 35108666 Free PMC article.

4

Tumor-targeting cell-penetrating peptide, p28, for glioblastoma imaging and therapy.

Mander S, Naffouje SA, Gao J, Li W, Christov K, Green A, Bongarzone ER, Das Gupta TK, Yamada T. Mander S, et al. Among authors: naffouje sa. Front Oncol. 2022 Jul 22;12:940001. doi: 10.3389/fonc.2022.940001. eCollection 2022. Front Oncol. 2022. PMID: 35936749 Free PMC article.

5

Assessment of Textbook Oncologic Outcomes Following Proctectomy for Rectal Cancer.

Naffouje SA, Ali MA, Kamarajah SK, White B, Salti GI, Dahdaleh F. Naffouje SA, et al. J Gastrointest Surg. 2022 Jun;26(6):1286-1297. doi: 10.1007/s11605-021-05213-9. Epub 2022 Apr 19. J Gastrointest Surg. 2022. PMID: 35441331

6

Outcomes of Open Versus Minimally Invasive Ivor-Lewis Esophagectomy for Cancer: A Propensity-Score Matched Analysis of NSQIP Database.

Naffouje SA, Salloum RH, Khalaf Z, Salti GI. Naffouje SA, et al. Ann Surg Oncol. 2019 Jul;26(7):2001-2010. doi: 10.1245/s10434-019-07319-6. Epub 2019 Mar 29. Ann Surg Oncol. 2019. PMID: 30927192

7

Feasibility of hand-assisted laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy.

Salti GI, Naffouje SA. Salti GI, et al. Among authors: naffouje sa. Surg Endosc. 2019 Jan;33(1):52-57. doi: 10.1007/s00464-018-6265-2. Epub 2018 Jun 20. Surg Endosc. 2019. PMID: 29926165

8

Surgical Management of Axilla of Triple-Negative Breast Cancer in the Z1071 Era: A Propensity Score-Matched Analysis of the National Cancer Database.

Naffouje SA, Barker V, Lee MC, Hoover SJ, Laronga C. Naffouje SA, et al. Ann Surg Oncol. 2022 May;29(5):2985-2997. doi: 10.1245/s10434-021-11194-5. Epub 2022 Jan 10. Ann Surg Oncol. 2022. PMID: 35006503

9

Delayed presentation of major complications in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy following hospital discharge.

Bhagwandin SB, Naffouje S, Salti G. Bhagwandin SB, et al. J Surg Oncol. 2015 Mar;111(3):324-7. doi: 10.1002/jso.23834. Epub 2014 Dec 31. J Surg Oncol. 2015. PMID: 25557653

10

Utility of Chemoresponse Assay in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy.

Bhagwandin S, Naffouje S, Salti G. Bhagwandin S, et al. Ann Surg Oncol. 2015 Aug;22(8):2573-7. doi: 10.1245/s10434-014-4330-1. Epub 2015 Jan 9. Ann Surg Oncol. 2015. PMID: 25572680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters